Klarquist News & Insights

Oregon animal nutrition company OmniGen Research and parent company Prince Agri Products prevailed on a motion for terminating sanctions due to the destruction of evidence in a suit against a former employee accused of stealing trade secrets. Klarquist argued that scientist Yongqiang Wang had misappropriated confidential information by trying to sell knock-offs of OmniGen’s feed […]

Read More

The Supreme Court ruled 8-0 that a domestic corporation’s residence — for purposes of the special federal “venue” statute governing where parties may be sued for patent infringement — is only its State of incorporation. The Court had so ruled 60 years ago, but the Court of Appeals for the Federal Circuit later ruled in […]

Read More

SunModo Corporation prevailed on summary judgment in a patent infringement suit brought by D Three Enterprises. D Three had alleged infringement of three patents relating to roof mount assemblies that can be used for solar panels. Klarquist argued invalidity of all of the 30+ asserted claims. On March 15, Judge Craig B. Shaffer ruled that […]

Read More

Klarquist Sparkman is pleased to announce that attorneys Ryan Andexer Farmer and Justin Foster have joined the firm. Mr. Farmer focuses his practice on the preparation and prosecution of patent applications. Prior to joining Klarquist, he practiced civil litigation and was a software engineer specializing in database development, GUIs, and technology related to business logic […]

Read More

Klarquist recently filed an amici brief on behalf of four of the country’s most prominent financial services member organizations in a Supreme Court case involving patent venue law that will be argued this spring. The organizations are asking the Supreme Court to follow its longstanding precedent limiting where patent suits may be filed and reject […]

Read More

Klarquist Partner Deakin Lauer was quoted in a January 26 Law360 article titled “AIA Estoppel Provision Not As Restricted As Many Expected.” The article discussed the America Invents Act’s inter partes review estoppel provision, which limits arguments to those seeking to invalidate patent claims that can be raised following PTAB review. The estoppel provision was […]

Read More